CIDRAP newsletters options
The vaccine trial is starting against a backdrop of a vigorous US outbreak, in which three states outside the main hot spots reported record highs: Oklahoma, Missouri, and North Dakota.
In a comparative analysis published late last week in Clinical Infectious Diseases, the antiviral drug remdesivir was linked to significantly greater recovery and a 62% lower death rate by day 14 versus standard treatment in hospitalized adults with severe COVID-19.
Two more Ebola infections and two more deaths from the virus have been reported from the Democratic Republic of the Congo (DRC) Equateur province outbreak, the World Health Organization (WHO) African regional office said on Twitter today.
"We need to reopen the schools with the understanding the virus is still here," CDC Director Robert Redfield says.
In India, surging COVID-19 has led to remdesivir shortages, and the outbreak is expanding in Brazil.
A study yesterday in The Lancet Child & Adolescent Health found no evidence of COVID-19 transmission between 120 babies born to mothers with COVID-19, even after 2 weeks of breastfeeding with appropriate hygiene precautions.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Scientists in Luxembourg this week announced the creation of a new biobank that will collect and analyze strains of bacteria from Europe that are resistant to last-resort antibiotics.
A plague outbreak in the Democratic Republic of the Congo (DRC) that began on June likely involves all three types, including pneumonic, and has so far resulted in 45 cases, 9 of them fatal, the World Health Organization (WHO) said yesterday in a statement.
WHO head reiterates that political leadership and community engagement are the 2 key response pillars.
July continues to look like April for the US, just as pro baseball opens.
About 47% of US adults have an underlying condition strongly tied to severe COVID-19 illness.
A 2019 survey of clinical commissioning groups in England showed an increase in antimicrobial stewardship (AMS) programs compared with the previous survey, according to a report yesterday from UK nonprofit The Patients Association.
A randomized controlled trial of hospitalized COVID-19 patients in Brazil found that the use of hydroxychloroquine, with or without azithromycin, did not improve clinical status at 15 days compared with standard care, researchers reported today in the New England Journal of Medicine.
Antibody levels dropped by about half every 73 days—not good news for vaccine prospects.
For the first time in more than a month, daily US deaths top 1,000.
Dr. Osterholm clarifies that he supports the wearing of cloth face coverings in public and urges people to stop citing CIDRAP and him as grounds for not wearing masks, but he also asks that advocates not use poorly conducted studies to support their use.
In the past day, the US, Brazil, and India reported more than 143,000 new cases combined.
Two more Ebola infections were confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, both of them in Mbandaka, the provincial capital, the World Health Organization (WHO) African regional office and its DRC office said on Twitter.
Early in the COVID-19 pandemic, US emergency department (ED) physicians said they were stressed by exposures to infected patients to the point that it impinged on their home lives and female ED doctors reported higher stress levels than their male counterparts, according to survey results published today in Academic Emergency Medicine.
Health officials see no let-up in the surge of COVID-19 cases in the Americas.
